XML 74 R67.htm IDEA: XBRL DOCUMENT
v3.25.2

Commitments and Contingencies - Additional Information (Detail) ¥ in Millions | 1 Months Ended | 6 Months Ended
--- | --- | ---
May 31, 2024 CNY (¥) | Jun. 30, 2025 USD ($) | Jun. 30, 2025 CNY (¥) | Jun. 30, 2024 USD ($)
Commitments And Contingencies Disclosure [Line Items] |  |  |  |
Purchase of property and equipment |  | $ 378,000 |  | $ 1,687,000
Property and Equipment |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |
Purchase of property and equipment |  | 4,000,000 |  |
Research and Development |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |
Committed to allocate |  | $ 22,000,000 |  |
Etorel IP Rights |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |
Contingent royalty minimum payment | ¥ | ¥ 35.0 |  |  |
Contingent royalty payment description |  | The contingent payment in the first year will be 5% of sales for that year minus RMB 10 million, or approximately $1.4 million, based on the June 30, 2025 spot exchange rate. The contingent payment in the second year will be 4% of sales for that year minus RMB 10 million, or approximately $1.4 million, based on the June 30, 2025 spot exchange rate. The contingent payments in the third year through the eighth year will be 3%, 2%, 2%, 1%, 1%, and 1% of sales in each year, respectively. | The contingent payment in the first year will be 5% of sales for that year minus RMB 10 million, or approximately $1.4 million, based on the June 30, 2025 spot exchange rate. The contingent payment in the second year will be 4% of sales for that year minus RMB 10 million, or approximately $1.4 million, based on the June 30, 2025 spot exchange rate. The contingent payments in the third year through the eighth year will be 3%, 2%, 2%, 1%, 1%, and 1% of sales in each year, respectively. |
Contingent royalty payment sales for first year | ¥ |  |  | ¥ 10.0 |
Contingent royalty payment sales for second year | ¥ |  |  | ¥ 10.0 |
Contingent royalty payment sales spot exchange rate for first year |  | $ 1,400,000 |  |
Contingent royalty payment sales spot exchange rate for second year |  | $ 1,400,000 |  |
Contingent royalty payment percentage of sale for first year |  | 5.00% |  |
Contingent royalty payment percentage of sale for second year |  | 4.00% |  |
Contingent royalty payments percentage of sale for third year |  | 3.00% |  |
Contingent royalty payments percentage of sale for fourth year |  | 2.00% |  |
Contingent royalty payments percentage of sale for fifth year |  | 2.00% |  |
Contingent royalty payments percentage of sale for sixth year |  | 1.00% |  |
Contingent royalty payments percentage of sale for seventh year |  | 1.00% |  |
Contingent royalty payments percentage of sale for eighth year |  | 1.00% |  |
Minimum payments based on spot exchange rate |  | $ 4,900,000 |  |
Hydronidone | GNI |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |
Committed to allocate |  | 12,700,000 |  |
Hydronidone | Gyre Pharmaceuticals |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |
Payments for exchange of intellectual property rights |  | 0 |  |
Hydronidone | Gyre Pharmaceuticals | Submission of the New Drug Application |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |
Obligation to pay in exchange for the intellectual property rights |  | 4,600,000 |  |
Hydronidone | Gyre Pharmaceuticals | NDA Passes the NMPA's Review and Inspection |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |
Obligation to pay in exchange for the intellectual property rights |  | 1,200,000 |  |
Hydronidone | Gyre Pharmaceuticals | NMPA's Approval of the NDA |  |  |  |
Commitments And Contingencies Disclosure [Line Items] |  |  |  |
Obligation to pay in exchange for the intellectual property rights |  | $ 6,900,000 |  |

X
- Definition Commitments and contingencies disclosure. + References No definition available. + Details
Name: | gyre_CommitmentsAndContingenciesDisclosureLineItems
Namespace Prefix: | gyre_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Committed to allocate. + References No definition available. + Details
Name: | gyre_CommittedToAllocate
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Contingent royalty minimum payment. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyMinimumPayment
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contingent royalty payment description. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentDescription
Namespace Prefix: | gyre_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contingent royalty payment percentage of sale for eighth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForEighthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for fifth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForFifthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for first year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForFirstYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for fourth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForFourthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for second year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForSecondYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for seventh year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForSeventhYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for sixth year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForSixthYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment percentage of sale for third year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentPercentageOfSaleForThirdYear
Namespace Prefix: | gyre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Contingent royalty payment sales for first year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentSalesForFirstYear
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contingent royalty payment sales for second year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentSalesForSecondYear
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contingent royalty payment sales spot exchange rate for first year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentSalesSpotExchangeRateForFirstYear
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contingent royalty payment sales spot exchange rate for second year. + References No definition available. + Details
Name: | gyre_ContingentRoyaltyPaymentSalesSpotExchangeRateForSecondYear
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum payments based on spot exchange rate + References No definition available. + Details
Name: | gyre_MinimumPaymentsBasedOnSpotExchangeRate
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Obligation to pay in exchange for the intellectual property rights. + References No definition available. + Details
Name: | gyre_ObligationToPayInExchangeForTheIntellectualPropertyRights
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Payments for exchange for intellectual property rights. + References No definition available. + Details
Name: | gyre_PaymentsForExchangeForIntellectualPropertyRights
Namespace Prefix: | gyre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=gyre_EtorelIPRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=gyre_HydronidoneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=gyre_GNIMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=gyre_GyrePharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=gyre_SubmissionOfTheNewDrugApplicationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=gyre_NDAPassesTheNMPAsReviewAndInspectionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=gyre_NMPAsApprovalOfTheNDAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |